If you havent lost at least 5% body weight by week 12, discuss dose escalation with your physician
In diet-induced obesity models: These findings suggest that the compounds effects are driven by metabolic reprogramming rather than appetite suppression, making it highly relevant for research into lipid metabolism and energy utilization
medical research institutions
The combination of ginkgetin and cisplatin (DDP) decreased the SLC7A11 and GPX4 expression as well as the GSH/GSSG ratio and increased labile iron pool and lipid peroxidation to mediate ferroptosis in EGFR wild-type non-small-cell lung cancer
Geib T, Iacob C, Jribi R, Fernandes J, Benderdour M, Sleno L
Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with type 2 diabetes mellitus and obesity: a randomized dose-ranging study